Cu-Med Pharmaceuticals Private Limited
About Cu-Med Pharmaceuticals Private Limited
Data last updated:
Cu-Med Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 05 February 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2021PTC376581. Its GSTIN is 07AAJCC2731J1ZO (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Sandeep Katyal and Arti Katyal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 396 First Floor Gagan Vihar Near Park, Delhi, India – 110051.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.92 Cr, a growth of 112% compared to the previous year. For the same year it recorded a net loss of ₹50.5 Lakh (net margin -6.4%) and EBITDA of -₹37.99 Lakh (EBITDA margin -4.8%).
As per MCA filings, the company has open charges of ₹50 Lakh on record.
Company details
Contact details
Cu-Med Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address396 First Floor Gagan Vihar Near Park, Delhi, India – 110051
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of Cu-Med Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Cu-Med Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Cu-Med Pharmaceuticals Private Limited, buy the company report.
Financials of Cu-Med Pharmaceuticals Private Limited
FY 2025 filings availableCu-Med Pharmaceuticals Private Limited reported revenue of ₹7.92 Cr (up 112% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 112% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹37.99 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹50.5 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -4.8% | ||||
| Net Profit Margin | -6.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cu-Med Pharmaceuticals Private Limited, buy the company report.
Board of directors of Cu-Med Pharmaceuticals Private Limited
Cu-Med Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandeep Katyal | Director | 05 Feb 2021 | 5 Years 8 Months | Current |
| Arti Katyal | Director | 05 Feb 2021 | 5 Years 8 Months | Current |
Auditor
Cu-Med Pharmaceuticals Private Limited is audited by S K G N & ASSOCIATES LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S K G N & ASSOCIATES LLP | FY 2023 | 023403N/N500052 |
Shareholding
The shareholding of Cu-Med Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Cu-Med Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Feb 2025 | 101072076 | Others | ₹50 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Cu-Med Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cu-Med Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Cu-Med Pharmaceuticals Private Limited has 1 active EPFO establishment as of Mar 31, 2024.
GST
Cu-Med Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAJCC2731J1ZO | Delhi | Active | 09 Dec 2021 |
To see the full GST registrations and return filing status of Cu-Med Pharmaceuticals Private Limited, buy the company report.
Recent activity
Cu-Med Pharmaceuticals Private Limited has 4 board changes on record since 2021: 3 appointments and 1 cessation. The latest: Prachi Dubey ceased to be Director on 10 Feb 2024.
Frequently asked questions
Cu-Med Pharmaceuticals is an active private limited company based in Delhi, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 05 February 2021 (5+ years old) and is registered under CIN U51909DL2021PTC376581.
Cu-Med Pharmaceuticals has 2 current directors:
- Sandeep Katyal - Director
- Arti Katyal - Director
The latest financial statements of Cu-Med Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Cu-Med Pharmaceuticals is 07AAJCC2731J1ZO, registered in Delhi.
The CIN (Corporate Identification Number) of Cu-Med Pharmaceuticals is U51909DL2021PTC376581. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cu-Med Pharmaceuticals was incorporated on 05 February 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
Prachi Dubey ceased to be Director on 10 Feb 2024. Prachi Dubey was appointed as Director on 30 Oct 2021. Arti Katyal was appointed as Director on 05 Feb 2021. Cu-Med Pharmaceuticals has 4 board changes on record in total.
The registered office of Cu-Med Pharmaceuticals is at 396 First Floor Gagan Vihar Near Park, Delhi, India – 110051.
Cu-Med Pharmaceuticals operates in the healthcare industry, in the medical equipment retail and distribution segment.
Cu-Med Pharmaceuticals has open charges of ₹50 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
